http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000511401-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2799-027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-036
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2812
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70542
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-625
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
filingDate 1997-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2000-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2000511401-A
titleOfInvention Adapter molecules that target viral particles to cells
abstract (57) [Summary]nThe present invention relates to molecular adapter molecules for targeting viral particles, especially retroviral particles, to cells. The adapter molecule comprises a first amino acid sequence having a binding affinity for a cell surface molecule and a second amino acid sequence having a binding affinity for a virus surface molecule. Adapter molecules are useful in gene therapy to target retroviral delivery vectors to specific cell types.
priorityDate 1996-02-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11987
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7412
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11989
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID22329
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID64006
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25361
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100032965
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457586576
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID107393082
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID559627
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2719
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6541
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0C781
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504623
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0C782

Total number of triples: 50.